ABEO Abeona Therapeutics Inc.
5.080USD+1.40%Mkt Cap: 290.49M $P/E: —1d ago
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy fo…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap290.49M USD
Enterprise Value159.54M USD
Revenue (TTM)25.52M USD
Gross Profit2.40M USD
Net Income (TTM)71.18M USD
Revenue/Share0.46 USD
Last Price5.080 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees226
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-24.14
PEG—
EV/EBITDA-1.98
EV/Revenue6.25
P/S11.23
P/B2.24
EPS (TTM)-1.16
EPS (Forward)-0.21
52W Range
4.00030% of range7.650
52W High7.650 USD
52W Low4.000 USD
Profitability
Gross Margin41.15%
Oper. Margin-119.97%
EBITDA Margin0.00%
Profit Margin1223.08%
ROE44.71%
ROA32.42%
Growth
Revenue Growth2745.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-76.33M USD
CapEx (TTM)7.97M USD
FCF Margin-287.61%
FCF Yield-25.27%
Net Debt-126.95M USD
Net Debt/EBITDA1.57
Balance Sheet
Debt/Equity0.16
Current Ratio6.63
Quick Ratio6.32
Book Value/Sh2.24 USD
Cash/Share2.57 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJul 5, 2022
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.88 USD
Upside (mean)+271.6%
Target Range14.00 USD – 30.00 USD
14.00+271.6% to mean30.00
# Analysts8
Ownership
Shares Out.57.18M
Float36.85M
Insiders10.96%
Institutions74.90%
Short Interest
Short Ratio12.9d
Short % Float29.55%
Short % Out.27.53%
Shares Short15.75M
Short (prev mo.)14.27M
Technical
SMA 505.957 (-14.7%)
SMA 2005.551 (-8.5%)
Beta1.30
S&P 52W Chg16.45%
Avg Vol (30d)1.24M
Avg Vol (10d)1.15M
Technical Indicators
RSI (14)35.8
MACD-0.2660
MACD Signal-0.2515
MACD Hist.-0.0145
BB Upper5.929 USD
BB Middle5.390 USD
BB Lower4.851 USD
BB Width20.01%
ATR (14)0.2386 USD
Vol Ratio (20d)0.56x